Form 4: National Healthcare Corp Director Abernathy Receives Stock Option Grant
SEC Form 4 Filing
Director James Paul Abernathy of National Healthcare Corp. reports the acquisition of 7,500 stock options on May 8, 2025, under the company's 2020 Omnibus Equity Incentive Plan.
Summary
- On May 8, 2025, James Paul Abernathy, a director at National Healthcare Corp (NHC), filed a Form 4 to report changes in beneficial ownership.
- The report details the grant of 7,500 stock options to Abernathy under the 2020 Omnibus Equity Incentive Plan.
- These options have an exercise price of $94.66 and expire on May 7, 2030, with the options exercisable from May 8, 2026.
- Abernathy directly owns 35,023 shares of common stock.
- Abernathy also holds options to purchase common stock from previous grants: 4,010 from 2021 (exercise price $71.64, expiring 05/05/2026), 7,500 from 2022 (exercise price $69.19, expiring 05/04/2027), 7,500 from 2023 (exercise price $55.75, expiring 05/03/2028), and 7,500 from 2024 (exercise price $96.03, expiring 05/08/2029).
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management interests with shareholders.
Positives
- The grant of stock options aligns the director's interests with those of the shareholders, incentivizing performance and value creation.
Industry Context
Stock option grants are a common practice in the healthcare industry to attract and retain key personnel, aligning their interests with the long-term performance of the company.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation across the healthcare sector.
- Companies like Brookdale Senior Living and Life Care Centers of America also utilize equity-based compensation to incentivize their leadership teams.
- The size and terms of the grant are generally in line with industry practices for director compensation.
Stakeholder Impact
- The stock option grant could have a positive impact on shareholders by incentivizing the director to improve company performance.
- Employees may view the grant as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 05/06/2022 | Exercisable date for 2021 option grant |
| 05/05/2023 | Exercisable date for 2022 option grant |
| 05/04/2024 | Exercisable date for 2023 option grant |
| 05/08/2025 | Date of the reported transaction (option grant) |
| 05/09/2025 | Exercisable date for 2024 option grant |
| 05/05/2026 | Expiration date for 2021 option grant |
| 05/08/2026 | Exercisable date for 2025 option grant |
| 05/04/2027 | Expiration date for 2022 option grant |
| 05/03/2028 | Expiration date for 2023 option grant |
| 05/08/2029 | Expiration date for 2024 option grant |
| 05/07/2030 | Expiration date for 2025 option grant |
Keywords
stock options, Form 4, National Healthcare Corp, NHC, director, James Paul Abernathy, beneficial ownership, equity incentive plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.